GPCRs and cancer

Rosamaria Lappano1, Marcello Maggiolini

  • 1Department of Pharmaco-Biology, University of Calabria, Rende, Italy.

Insights

G-protein-coupled receptors (GPCRs) are key in cell signaling and cancer. This review explores how GPCRs influence tumor growth and metastasis, offering insights for new cancer therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • G-protein-coupled receptors (GPCRs) constitute the largest human gene family.
  • GPCRs mediate physiological functions and are implicated in tumor growth and metastasis.
  • These receptors transduce signals from various molecules like hormones and neurotransmitters.

Purpose of the Study:

  • To review emerging information on GPCR-mediated responses in cancer.
  • To elucidate molecular mechanisms of GPCR action in cancer progression.
  • To identify novel pharmacological targets for cancer treatment.

Main Methods:

  • Literature review of GPCRs in cancer biology.
  • Analysis of signaling pathways modulated by GPCRs.
  • Examination of GPCRs' role in tumor cell activity.

Main Results:

  • GPCRs play a significant role in tumor growth and metastasis.
  • Integrated signaling networks involving GPCRs are crucial for tumor development.
  • Specific GPCRs exert primary actions in cancer progression.

Conclusions:

  • GPCRs are critical regulators of cancer progression.
  • Understanding GPCR mechanisms can lead to novel therapeutic strategies.
  • Targeting GPCRs offers potential for improved cancer patient outcomes.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...